NNMT
NNMT (nicotinamide N-methyltransferase) is a cytoplasmic enzyme that transfers a methyl group from S-adenosyl-L-methionine to nicotinamide, forming N1-methylnicotinamide. Through this reaction it links vitamin B3 clearance to cellular methylation potential, NAD(+) levels and xenobiotic metabolism. Browse Assay Genie's current range of NNMT research reagents below, or read on for the biology behind the target.
NNMT catalyses the N-methylation of nicotinamide using the universal methyl donor S-adenosyl-L-methionine (SAM). The products are N1-methylnicotinamide and S-adenosyl-L-homocysteine, and this reaction is a predominant clearance pathway for nicotinamide, also known as vitamin B3. Because the enzyme consumes SAM, it plays a central role in regulating cellular methylation potential and limits the SAM available to other methyltransferases. NNMT can also N-methylate other pyridines structurally related to nicotinamide, and it contributes to xenobiotic detoxification. The NCBI Gene summary notes that N-methylation is one route by which the liver metabolises drugs and other xenobiotic compounds.
The NNMT gene encodes a cytoplasmic protein that belongs to the class I-like SAM-binding methyltransferase superfamily and the NNMT/PNMT/TEMT family. HGNC places it among the 7BS small molecule methyltransferases. The mouse ortholog is Nnmt, which is relevant when choosing a model system for work on the human NNMT protein.
Beyond small-molecule clearance, NNMT acts as a metabolic and epigenetic regulator. By consuming SAM it drives genome-wide epigenetic and transcriptional changes through hypomethylation of repressive chromatin marks such as H3K27me3, and it contributes to the low levels of repressive histone marks that characterise the pre-implantation pluripotent embryonic stem cell state. In white adipose tissue it influences energy expenditure. In white adipocytes it regulates polyamine flux by consuming SAM, and it controls NAD(+) levels through the salvage pathway by consuming nicotinamide. It also affects hepatic gluconeogenesis and cholesterol biosynthesis. In hepatocytes, N1-methylnicotinamide represses ubiquitination and increases the stability of the SIRT1 deacetylase, so NNMT also influences protein acetylation.
NNMT consumes SAM and promotes hypomethylation of repressive chromatin marks such as H3K27me3, making it a focus for studies of methylation potential.
In white adipocytes NNMT regulates polyamine flux and NAD(+) levels through the salvage pathway, and it influences energy expenditure.
NNMT affects hepatic gluconeogenesis and cholesterol biosynthesis, and its product N1-methylnicotinamide stabilises SIRT1 in hepatocytes.
NNMT N-methylates nicotinamide-related pyridines and contributes to the hepatic metabolism of drugs and other xenobiotic compounds.
NNMT methylates nicotinamide using S-adenosyl-L-methionine, producing N1-methylnicotinamide and S-adenosyl-L-homocysteine. This clears vitamin B3 and, by consuming SAM, regulates cellular methylation potential. It also affects NAD(+) levels, polyamine flux, histone methylation and xenobiotic detoxification.
NNMT belongs to the class I-like SAM-binding methyltransferase superfamily and the NNMT/PNMT/TEMT family. HGNC lists it in the small molecule methyltransferases group. Its EC number is 2.1.1.1, and the protein is found in the cytoplasm.
Yes. The mouse ortholog is Nnmt, and mouse studies have informed understanding of its roles in adipose tissue energy expenditure and hepatic metabolism. Check the datasheet of any product for its validated reactivity before using it in a given species.
Other methyltransferases, NAD(+) metabolism enzymes and epigenetic regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P40261; product specifications from Assay Genie datasheets.